正邦科技(002157.SZ):境外子公司擬發行不超6000萬美元債券
格隆匯6月25日丨正邦科技(002157.SZ)公佈,公司於2021年6月25日召開第六屆董事會第十四次臨時會議,審議通過了《關於全資子公司在境外發行債券暨對外擔保的議案》及《關於提請股東大會授權公司經營管理層全權辦理本次境外發行債券相關事宜的議案》,同意公司境外全資子公司(該公司暫未成立,“SPV”)在境外發行不超過6000萬美元(含6000萬美元,或等額離岸人民幣或其他外幣)債券,並由公司為此次發行提供無條件及不可撤銷的跨境連帶責任保證擔保。
此次發行境外債券的募集資金擬用於養殖項目建設、債務置換及原材料採購等符合國家法律法規及政策要求的企業經營活動
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.